| European Case Law Identifier: | ECLI:EP:BA:2017:T181812.20170209 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 09 February 2017 | ||||||||
| Case number: | T 1818/12 | ||||||||
| Application number: | 05803527.0 | ||||||||
| IPC class: | C07K 16/00 C12N 1/00 B01D 15/00 C12P 21/00 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Process for obtaining antibodies | ||||||||
| Applicant name: | UCB Pharma, S.A. | ||||||||
| Opponent name: | Zimmer, Franz-Josef | ||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Sufficiency of disclosure - (yes) Inventive step - main request (yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t121818eu1.html
Date retrieved: 17 May 2021